University of Cambridge > Talks.cam > Seminars at the Department of Biochemistry > Horizon’s Adventures in CRISPR land

  Browse A-Z

Log in

Googledetails Microsoftdetails

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹ️ Information

Horizon’s Adventures in CRISPR land

Download to your calendar using vCal

If you have a question about this talk, please contact .

CRISPR -Cas9 gene editing has received a lot of publicity over recent years. Often presented as an ‘easy’ route to gene modification, like any other biological process, CRISPR -Cas9 has its advantages and challenges. For drug discovery, CRISPR -Cas9 screens have been touted as the new and improved platform for target identification and validation – perceived to have many advantages and few disadvantages compared with siRNA. This talk will focus on whether this viewpoint is justified and whether CRISPR -Cas9 screens will help to move more robust targets into cancer-specific drug discovery.

This talk is part of the Seminars at the Department of Biochemistry series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Jean Thomas Lecture Theatre - Department of Biochemistry, Sanger Building Hybrid, Seminar Room (1st floor), Civil Engineering Building, 7a JJ Thomson Ave, Cambridge CB3 0FA Wolfson Lecture Theatre & ONLINE - Details to be sent by email

Other talks

TBC Morning Tea and Coffee External Seminar - Michael Raissig TBC Dwarf Galaxies in the Local Universe Topic Film, TV shows for Medical Education, ‘The Wire’ as a case study Royal Papworth Hospital and Acute Medicine
 

© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity